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Abstract 
Background: Endothelial progenitor cells (EPCs) have been suggested to constitute a restoration index of the 
disturbed endothelium in ICU patients. Neuromuscular electric stimulation (NMES) is increasingly employed in ICU to 
prevent comorbidities such as ICU-acquired weakness, which is related to endothelial dysfunction. The role of NMES 
to mobilize EPCs has not been investigated yet. The purpose of this study was to explore the NMES-induced effects 
on mobilization of EPCs in septic ICU patients.
Methods: Thirty-two septic mechanically ventilated patients (mean ± SD, age 58 ± 14 years) were randomized 
to one of the two 30-min NMES protocols of different characteristics: a high-frequency (75 Hz, 6 s on–21 s off ) or a 
medium-frequency (45 Hz, 5 s on–12 s off ) protocol both applied at maximally tolerated intensity. Blood was sampled 




Results: Overall, CD34+/CD133+/CD45− EPCs increased from 13.5 ± 10.2 to 20.8 ± 16.9 and CD34+/CD133+/CD45−/
VEGFR2
+ EPCs from 3.8 ± 5.2 to 6.4 ± 8.5 cells/106 enucleated cells (mean ± SD, p < 0.05). CD34+/CD45−/VEGFR2+ 
EPCs also increased from 16.5 ± 14.5 to 23.8 ± 19.2 cells/106 enucleated cells (mean ± SD, p < 0.05). EPCs mobiliza-
tion was not affected by NMES protocol and sepsis severity (p > 0.05), while it was related to corticosteroids adminis-
tration (p < 0.05).
Conclusions: NMES acutely mobilized endothelial progenitor cells, measures of the endothelial restoration potential, 
in septic ICU patients.
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Background
Endothelium, a key regulator of homeostasis, is disturbed 
in ICU patients and is associated with multi-organ failure 
[1]. The relation of endothelial function with endothe-
lial progenitor cells (EPCs) has been shown for differ-
ent groups, such as healthy populations with or without 
cardiovascular risk factors [2, 3], patients with coronary 
artery disease [4] and chronic heart failure (CHF) [5]. 
Accumulating evidence has suggested multiple roles for 
EPCs in endothelial physiology, such as neovasculariza-
tion, endothelial repair and restoration of endothelial 
function [6]. EPCs are bone marrow-derived precursors 
of endothelial cells with potential capacity to proliferate, 
migrate, differentiate or exert paracrine action.
Neuromuscular electrical stimulation (NMES), sug-
gested as an alternative form of exercise in critically 
ill patients, seems to be potentially beneficial in pre-
serving muscle strength and muscle mass as well as in 
reducing the duration of weaning and the incidence 
of ICU-acquired weakness [7–10]. Acutely applied 
NMES in ICU also induced systemic beneficial effects 
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on the microcirculation, which is closely related to 
endothelial function [11]. Furthermore, increased 
EPCs levels have been observed in response to acute 
bouts of exercise in healthy populations [12–14] and 
patients with CHF [5]. However, the role of acute 
NMES in raising EPCs counts in ICU patients has not 
been investigated yet.
It was hypothesized that an NMES session would 
increase counts of EPCs in severe ICU patients. The main 
purpose of this study was to explore the role of acutely 
applied NMES on mobilizing progenitor endothelial cells 
in septic critically ill patients.
Methods
Patients
Patients admitted to the multi-disciplinary ICUs of Evan-
gelismos Athens General Hospital were considered for 
inclusion. Inclusion criteria were the presence of sepsis 
for >72  h and mechanical ventilation. Determination of 
sepsis was based on criteria, as previously described [15]. 
Exclusion criteria were age <18 and >80 years, pregnancy, 
moribund, body mass index (BMI) >35  kg/m2, severe 
edema (deep indentation when pressing finger into 
skin, requiring >30  s to rebound), ICU-acquired weak-
ness, ICU length of stay ≥20 days prior to study enroll-
ment, history of neuromuscular disease at admission, 
implanted pacemaker/defibrillator, technical restrictions 
not allowing NMES application (e.g., bone fractures 
or skin lesions), thromboembolic disease, continuous 
hemodialysis, ongoing transfusion, and chemotherapy or 
other forms of myelotoxicity.
Study design
This was a prospective randomized study. Eligible 
patients were randomized to one session of NMES using 
one of the two protocols with different characteristics. 
Blood samples were collected before and within 5  min 
after the session for flow cytometry analyses. Mean arte-
rial blood pressure, heart rate, respiratory rate and ECG 
were monitored during the session. Lactate and creatine 
phosphokinase were also recorded before and after the 
NMES application. Primary end-point was the NMES 
effect on the number of EPCs. Other end-points were 
the effects of different NMES protocols, corticosteroids 
administration and sepsis severity on EPCs number. For 
the purpose of the latter end-point, patients were divided 
into two subgroups based on the median SOFA score 
on the NMES session day (lower SOFA score group ≤6; 
higher SOFA score group >6).
The study was conducted in accordance with the Decla-
ration of Helsinki and approved by the ethics committee 
of the hospital. Written informed consent was obtained 
by the patients or their next of kin.
Application of neuromuscular electrical stimulation
For NMES application (Rehab 4 Pro, CEFAR Medical AB, 
Malmö, Sweden), rectangular electrodes (90 ×  50  mm) 
were placed on the motor points of vastus lateralis, vastus 
medialis and peroneus longus of both lower extremities, 
after appropriate skin preparation. During the session, 
the angle of the patients’ knee joint was approximately 
40° (0° corresponding to full knee extension). NMES ses-
sions lasted for 40  min including 10  min for warm-up 
and recovery (10 Hz, 400 μs).
Patients were assigned to a high-frequency (HF) 
or a medium-frequency protocol (MF), as previously 
described [16]. In short, both protocols employed sym-
metric, biphasic, trapezoid pulses, with 400-μs pulse 
duration and 1.5/0.8-s ramp-up/ramp-down dura-
tion, respectively. HF consisted of 75  Hz pulses with 
6  s on–21  s off. MF consisted of 45  Hz pulses with 5  s 
on–12  s off. Current intensity, optimally aiming at full 
muscle contraction, was continuously increased dur-
ing the sessions, to prevent fatigue. In sedated patients, 
starting intensity was set at 60–80 % of that resulting in 
maximal response and increased by 10 % every 3 min up 
to 100 %. In non-sedated patients, intensity was initially 
set to the maximum tolerated level and was increased by 
10 % (or less in case of discomfort) every 3 min through-
out the session.
Blood sampling and flow cytometry analyses
For evaluation of EPCs, blood samples were drawn from 
an antecubital or existing central vein; the first 3 ml were 
discarded. Venous blood was collected in acid citrate 
dextrose tubes of 5 ml capacity 5 min before and at the 
end of the NMES sessions and was processed within 3 h 
of collection. Blood samples were kept at 4  °C through-
out the procedure. Whole peripheral blood samples were 
analyzed by flow cytometry [17]. During the procedure, 
fresh samples were centrifuged at 700 g for 20 min with 
no brake. The upper phase (plasma) was gently removed 
into a separate tube and stored in 0.25 ml aliquots. The 
lower phase containing the blood cells was resuspended 
using 10 ml of cold 1 × PBS containing 0.5 % (w/v) BSA 
and 1.5 mM EDTA and centrifuged at 700 g for 20 min 
with no brake for a second time. The upper phase was 
removed and discarded; the cell pellet was resuspended, 
and 2.5 ml was transferred into a separate tube and kept 
on ice. Concomitantly, 500 μl of samples was also trans-
ferred into one isotype control and three sample tubes 
and the appropriate antibodies were added: Then, 9  ml 
of ACK lysing buffer was added (to lyse red blood cells), 
vortexed briefly and incubated at room temperature 
(18–25  °C) for 3 min. It was washed twice with 9 ml of 
cold regular 1 × PBS and centrifuged at 250 g at 4 °C with 
brake for 5 min. The cell pellet was resuspended in 500 μl 
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of 1 × PBS, and the samples were filtered through 40-μm 
cell strainer into 5-ml BD Falcon tubes. The tubes were 
held at 4 °C (or on ice) in the dark before acquisition on 
the flow cytometer. Flow cytometry was performed in 
the Flow Cytometry Core Laboratory with BDFACSCan-
toII (Becton–Dickinson) flow cytometer. An acquisition 
gate was established that included mononuclear cells but 
excluded most granulocytes and debris; 106 mononu-
clear events were routinely collected to determine this 
population. Finally, Boolean analysis using combination 
of specific surface markers was applied. Different EPCs 
subpopulations were quantified by cytometry mark-
ers CD34+/CD133+/CD45−, CD34+/CD133+/CD45−/
VEGFR2+ and CD34+/CD45−/VEGFR2+ [17, 18] (Fig. 1).
Statistical analyses
Continuous variables are reported as mean  ±  standard 
deviation (SD). Normality of distribution was checked 
with Kolmogorov–Smirnov test. Student’s paired t test 
or Wilcoxon signed-rank test (in case of not normal dis-
tribution) was employed for within-group differences. 
Differences between subgroups were assessed with facto-
rial analysis of variance (ANOVA) 2 × 2 (time × group). 
Effect size was calculated as mean of the difference/SD of 
the difference. Statistical significance was set to p < 0.05. 
Statistical analyses were performed with IBM SPSS 20.
Results
Thirty-two patients were included. Demographic and 
clinical characteristics are presented in Table  1. No dif-
ference was observed in these characteristics between 
subgroups (p > 0.05) in terms of NMES protocols, ster-
oids administration and sepsis severity. Concerning 
sepsis severity, SOFA score was higher in the higher 
SOFA group (p = 0.04) (data not shown). NMES sessions 
took place on 7.6 ± 0.8 days from admission.
In the whole group, NMES increased CD34+/CD133+/
CD45− EPCs from 13.5 ±  10.2 to 20.8 ±  16.9 cells/106 
enucleated cells (+54  %, corresponding to effect size: 
0.46, p =  0.02) (Figs.  2, 3). In regard to subgroup com-
parisons (Table  2), this EPCs population increased in 
MF (p =  0.04), but not in HF (p =  0.18). No between-
protocol differences were observed (p =  0.60). Baseline 
number was lower in MF than HF (p  =  0.03). CD34+/
CD133+/CD45− EPCs count also increased in the 
nonsteroids (p  <  0.01), but not in the steroids group 
(p  =  0.46). A significant between-group difference was 
observed (p  =  0.02), while no difference was found in 
baseline number (p  =  0.21). Finally, lower SOFA score 
(p  =  0.04) and higher SOFA score patients (p  =  0.07) 
increased CD34+/CD133+/CD45− EPCs number, with 
no between-group difference either in total (p = 0.88) or 
at baseline (p = 0.95).  
Similar results were observed for CD34+/CD133+/
CD45−/VEGFR2+ EPCs, which were increased in the 
whole cohort from 3.8 ± 5.2 to 6.4 ± 8.5 cells/106 enu-
cleated cells (+68  %, corresponding to effect size: 0.33, 
p =  0.04) (Figs.  2, 3). In relation to subgroup compari-
sons (Table  2), these were tended to increase in MF 
(p = 0.06), but not in HF (p = 0.31), while no between-
protocol difference was found (p  =  0.91). CD34+/
CD133+/CD45−/VEGFR2+ EPCs count increased in 
the nonsteroids (p < 0.01), but not in the steroids group 
(p  =  0.17); a significant between-group difference was 
observed (p < 0.01). Finally, higher SOFA score (p = 0.04) 
but not lower SOFA score patients (p = 0.50) increased 
Fig. 1 Representative dot plot FACS analysis for endothelial progenitor cells determination. Boolean analysis was performed. In all samples, the 
CD34 expression was dim
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CD34+/CD133+/CD45−/VEGFR2+ EPCs number, with 
no between-group difference (p = 0.43). In addition, no 
differences between subgroups at baseline were found for 
all comparisons employed (p > 0.05).
In relation to CD34+/CD45−/VEGFR2+ EPCs, the 
entire group increased number from 16.5  ±  14.5 to 
23.8  ±  19.2 cells/106 enucleated cells (+44  %, cor-
responding to effect size: 0.42, p  <  0.01) (Figs.  2, 3). Its 
count did not change in HF (p = 0.13), while it increased 
in MF (p = 0.03). It was also increased in the nonsteroids 
(p < 0.01), but not in the steroids group (p = 0.84). Finally, 
higher SOFA score group (p = 0.01), but not lower SOFA 
patients (p =  0.24), increased CD34+/CD45−/VEGFR2+ 
EPCs number. No significant between-group difference 
was found in terms of NMES protocol (p =  0.20), ster-
oid administration (p = 0.21) or sepsis severity (p = 0.82) 
(Table 2).
In the whole group during the NMES sessions, there 
were increases in heart rate (from 89 ±  20 to 92 ±  19 
beats/min, p = 0.04) and respiratory rate (from 21 ± 6 to 
22 ± 6 breaths/min, p = 0.03), while mean arterial pres-
sure did not change (from 89 ±  11 to 92 ±  17  mmHg, 
p = 0.19). Increases were also observed in creatine phos-
phokinase (from 498 ± 961 to 526 ± 1011 IU/L, p < 0.01) 
and lactate (from 1.1 ± 0.4 to 1.4 ± 0.6 mmol/L, p < 0.01). 
No ECG and hemodynamic derangements occurred dur-
ing the sessions.
Discussion
This study showed that a single NMES session increased 
counts of endothelial progenitor cells in critically ill 
patients with sepsis. To the best of our knowledge, this is 
Table 1 Demographic and  clinical characteristics 
of patients included in the study
APACHE acute physiology and chronic health evaluation, SOFA sequential organ 
failure assessment
a Values are expressed as mean ± SD
Patients included, n 32
Age (years)a 58 ± 14
Gender (male/female) 23/9
APACHE II score on admissiona 21 ± 8
SOFA score on admissiona 7 ± 3
SOFA score on session daya 7 ± 3
Diagnostic category at admission
Post-surgery [n (%)] 12 (38 %)
Respiratory failure [n (%)] 8 (25 %)
Cardiovascular failure [n (%)] 4 (12 %)
Trauma [n (%)] 3 (9 %)
Neurological [n (%)] 3 (9 %)
Other [n (%)] 2 (6 %)
Comorbidities
Cardiovascular disease [n (%)] 19 (59 %)
Respiratory disease [n (%)] 5 (16 %)
Hepatic disease [n (%)] 5 (16 %)
Renal disease [n (%)] 5 (16 %)
Diabetes mellitus [n (%)] 12 (38 %)
Hematological/anticoagulated [n (%)] 6 (19 %)
Other [n (%)] 21 (66 %)
Medication on session day
Corticosteroids [n (%)] 10 (31 %)
Antimicrobials [n (%)] 30 (94 %)
Noradrenaline [n (%)] 12 (38 %)
Sedative [n (%)] 15 (47 %)
































Fig. 2 Change of the three EPCs subpopulations number (mean + SD) before and after the NMES sessions. EPCs endothelial progenitor cells; aster-
isk significant difference compared to pre-NMES value (p < 0.05)























































































Fig. 3 Change of EPCs number before and after the NMES sessions for each of the 32 patients included. a CD34+/CD133+/CD45− EPCs, b CD34+/
CD133+/CD45−/VEGFR2
+ EPCs, c CD34+/CD45−/VEGFR2
+ EPCs. EPCs endothelial progenitor cells
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the first study to demonstrate NMES efficacy on mobiliz-
ing progenitor cells, an index of the endothelium restora-
tion potential, in ICU patients.
Previous pilot studies, exploring the effects of short-
term protocols employing NMES in combination with 
intermittent hypobaric hypoxia or exercise, have shown 
increased number of progenitor cells in healthy subjects 
and patients with traumatic brain injury [19, 20]; obvi-
ously, these studies are not feasible to compare with our 
study.
In ICU patients, NMES seems to prevent muscle weak-
ness and improve muscle strength [8, 9] while it has 
also the potential to prevent muscle atrophy [7, 10, 21]. 
Acutely applied NMES can induce systemic beneficial 
effects on microcirculation, which is related to mecha-
nisms of ICU-acquired weakness, including disturbances 
in macro- and microvascular function [22, 23]. Further 
evidence suggests that NMES can reduce ICU-acquired 
weakness incidence and duration of weaning, although 
this needs to be verified by large RCTs [9, 24]. From these 
points of view, NMES has been suggested as a form of 
exercise to mobilize and induce rehabilitative interven-
tions to ICU patients [25]. There is also increasing interest 
in the NMES role concerning therapy of pressure ulcers 
[26] and prevention of deep vein thrombosis [22, 23].
Previous studies have also demonstrated increased lev-
els of EPCs subpopulations or their migratory capacity 
in response to acute bouts of aerobic exercise in healthy 
populations and other critically ill patients, such as 
patients with CHF [5, 14]. These effects were attenuated 
in CHF [27]. Interestingly, recent data also suggested a 
beneficial effect of acute resistance training on improv-
ing EPCs counts and angiogenic factors in healthy sub-
jects [13]. NMES, as applied in this study, may have more 
similarities to resistance exercise in that it stimulated iso-
lated muscle groups.
Shear stress may be suggested as a triggering factor for 
EPCs release after a single NMES session. Shear stress-
induced up-regulation and increased activity of endothe-
lial nitric oxide synthase are related to increased nitric 
oxide production by endothelial cells [28], contributing 
to amplified number and activity of circulating EPCs [3]. 
NMES application on the calf muscles of healthy subjects 
and patients after total hip replacement surgery acutely 
increased popliteal blood flow and volume flow, reflecting 
increases in shear stress-induced vasodilatation [22, 23]. 
The importance of ischemic/hypoxic stimulus to increase 
EPCs count has been also implied in short-term studies 
enrolling patients with cardiovascular disease [29]. In a 
recent animal study, short-term NMES-induced ischemic 
training moderately increased EPCs [30]. EPCs have 
been also increased in response to acute exercise- and 
non-exercise-induced ischemic stimulus in patients with 
peripheral arterial occlusive disease and healthy partici-
pants, respectively [31]. NMES, mainly resulting in iso-
metric contractions, has the potential to induce hypoxic 
stimuli, as suggested by alterations in microcirculation 
indices during NMES sessions in healthy populations 
[32] and ICU patients [16]. These mechanisms may relate 
to up-regulation of transcriptional factors, such as matrix 
metalloproteinases, stromal cell-derived factor 1 and vas-
cular endothelial growth factor, which mediate processes 
to promote proliferative and migratory capacities of cir-
culating EPCs [5, 13, 31]. The proposed mechanisms and 
mediating factors in relation to the different subpopula-
tions of progenitor cells, as well as the time course of the 
changes, should be addressed in future studies exploring 
the effects of NMES in ICU patients.
Table 2 EPCs numbers (cells/million enucleated cells, mean ±  SD) before  and after  NMES sessions for  the subgroups 
in terms of NMES protocol, steroids administration and sepsis severity
EPCs endothelial progenitor cells, HF high-frequency NMES protocol, MF medium-frequency NMES protocol
* p value for within-group differences; # p value for between-group differences





Pre- Post- p* p# Pre- Post- p* p# Pre- Post- p* p#
By NMES protocols
HF 18.0 ± 11.6 23.6 ± 18.1 0.18 0.60 4.8 ± 4.6 7.3 ± 9.4 0.31 0.91 15.9 ± 15.6 18.6 ± 11.6 0.13 0.20
MF 10.1 ± 7.6 18.7 ± 16.1 0.04 2.9 ± 5.6 5.8 ± 8.0 0.06 17.0 ± 14.1 28.0 ± 23.0 0.03
By steroids administration
Steroids 16.7 ± 8.8 14.2 ± 8.6 0.46 0.02 5.5 ± 7.5 2.6 ± 2.3 0.13 <0.01 21.0 ± 19.3 22.5 ± 22.5 0.84 0.21
Nonsteroids 12.1 ± 10.6 23.8 ± 19.0 <0.01 3.0 ± 3.7 8.2 ± 9.8 <0.01 14.5 ± 11.8 24.5 ± 18.1 <0.01
By sepsis severity
Lower SOFA score patients 13.4 ± 10.1 22.5 ± 20.9 0.04 0.88 3.3 ± 3.7 4.9 ± 7.7 0.50 0.43 14.9 ± 15.6 21.4 ± 17.8 0.24 0.82
Higher SOFA score patients 13.2 ± 9.6 21.4 ± 13.8 0.07 4.6 ± 6.4 8.5 ± 9.4 0.04 16.6 ± 13.1 24.7 ± 19.9 0.01
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An interesting finding was that patients on corticoster-
oids did not increase progenitor cells in contrast to patients 
not on steroids. Corticosteroids may affect EPCs mobiliza-
tion and activity. Previous studies on EPCs mobilization 
and function employing patients on corticosteroids medi-
cation have provided similar [33, 34], neutral [35] or con-
trasting results [36, 37]. In the latter studies, this finding 
could be related to the fact that steroids administration had 
a stronger effect on interleukin 1 reduction and rheumatic 
disease remission—the main cause of progenitor cells sup-
pression—than EPCs number per se [38]. In this study, no 
difference was detected between the two corticosteroids 
subgroups at baseline EPCs counts and that was also the 
case for SOFA and APACHE scores. Several confounding 
factors such as small sample size, severity of disease (not 
able to be reflected on conventional scales, such as SOFA 
score) and presence of inflammation may have interfered 
with these observations. Further research is necessary to 
explore the role of corticosteroids on mobilizing EPCs in 
response to NMES before reaching definite conclusions.
Both medium- and high-frequency protocols were 
found to similarly increase EPCs. Although MF, but 
not HF, was found to amplify EPCs count, this may be 
related to the sample size, since no interaction effect was 
observed. Another confounding factor might also be the 
distribution of sedated and awake patients in the NMES 
protocol subgroups, resulting in differences related to 
current tolerance and evoked muscle contraction. In a 
previous study of our group employing similar NMES 
protocols, both currents were equally effective in improv-
ing thenar oxygen consumption rate, endothelial reactiv-
ity and vascular reserve as well as oxygen consumption, 
demand and supply at the stimulated muscle, measures 
of systemic and local microcirculation, respectively. These 
improvements were well correlated to the strength of 
contraction [16]. Interestingly in another study, oxygen 
consumption in the biceps brachii during isometric con-
traction—which could be considered to reflect the magni-
tude of hypoxic stimuli of the working muscle—increased 
in proportion to the force developed [39]. In this study, 
although muscle strength contraction was not system-
atically recorded, some patients were hardly responded 
to NMES (no contraction at all or just palpable contrac-
tion), as previously observed [40]; however, all patients, 
‘responders’ and ‘non-responders,’ were included in the 
analysis, which, in turn, might be related to the marked 
variability observed among patients. The optimal NMES 
characteristics to apply in ICU patients are still under 
investigation [8]. Future studies should further explore the 
role of NMES to mobilize progenitor cells in relation to 
strength contraction of the stimulated muscle.
Although ICU patients most to benefit from NMES 
application have not yet clearly determined, septic 
patients are definitely a target group of interest. Sepsis 
induces endothelial and microcirculation dysfunction 
and is a risk factor for multi-organ failure and ICU-
acquired weakness [1, 41]. Endothelial restoration capac-
ity is impaired in sepsis, and circulating EPCs have been 
suggested to inversely associate with SOFA score and 
organ dysfunction [42]. Recently, exogenously adminis-
tered EPCs in septic mice increased anti-inflammatory 
mediators, attenuated liver and kidney injury, augmented 
markers of endothelial cell function/inflammation and 
EPCs recruitment, and improved survival [43]. In this 
study, both SOFA-based severity subgroups increased 
EPCs, likely implying that NMES has the potential to 
mobilize progenitor cells in septic patients irrespective of 
severity status; however, the clinical implications of this 
finding need to be explored.
In this study, small—although significant—increases in 
heart rate, respiratory rate, creatine phosphokinase and 
lactate were also observed due to NMES application. 
Interestingly, progenitor cells mobilization after acute 
exercise was recently related to creatine phosphokinase 
as a marker of ‘muscle damage’; whether the increase 
seen in this study might have a role, remains to be elu-
cidated [12]. Overall, these increases, seemingly having 
not any clinical significance for ICU patients, are rather 
reflective of a systemic effect of NMES, in line with pre-
vious findings from our group [11, 16]. The absence of 
any clinically significant side effects in terms of cardiac/
hemodynamic derangements and ‘muscle damage’ fur-
ther emphasizes on the NMES role as a safe and well-tol-
erated intervention in critically ill patients.
On the whole, our findings provide evidence that 
NMES mobilizes EPCs in ICU patients, measures of the 
endothelial restoration potential. Increased mobiliza-
tion of EPCs was approached in terms of counts eleva-
tion rather than functional improvement; since increased 
EPCs counts do not necessarily reflect elevated function, 
future studies should also address NMES efficacy to affect 
functional aspects of these cells categories. Accumulating 
evidence also supports the significance of NMES con-
cerning prevention of ICU-acquired weakness, as well 
as its potential role in the prevention of thromboembo-
lism and pressure ulcers, comorbidities of critical illness 
related to disturbed endothelial function. The relation of 
NMES-induced EPCs mobilization to prevention of these 
comorbidities warrants further investigation.
A limitation of the study was the small sample size of 
the patients included; comparisons between or within 
subgroups were, in some instances, underpowered to 
demonstrate differences in progenitor cells alterations. 
In addition, strength contraction and current intensities 
were not systematically recorded, which could possibly 
allow for further insight into the potential mechanisms 
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of EPCs mobilization; however, by design, current inten-
sities applied—optimally aiming at full muscle contrac-
tion—were the maximal tolerated by non-sedated and 
sedated patients, implying maximum applicable contrac-
tion in each case.
Conclusion
NMES acutely mobilized EPCs in severe ICU patients. 
These effects were not dependent on NMES protocol or 
sepsis severity status, while they were observed to relate 
to corticosteroids administration. These later findings the 
NMES-induced mechanisms of improved EPCs mobi-
lization and their clinical consequences warrant further 
investigation.
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